Oct4: The Final Frontier, Differentiation Defining Pluripotency  by Livigni, Alessandra & Brickman, Joshua M.
Developmental Cell
PreviewsOct4: The Final Frontier,
Differentiation Defining PluripotencyAlessandra Livigni1 and Joshua M. Brickman1,2,*
1MRC Centre for Regenerative Medicine, Institute for Stem Cell Research, School of Biological Sciences, 5 Little France Drive, University of
Edinburgh, Edinburgh EH16 4UU, UK
2The Danish Stem Cell Centre, DanStem, University of Copenhagen, 3B Blegdamsvej, DK-2200 Copenhagen, Denmark
*Correspondence: joshua.brickman@sund.ku.dk
http://dx.doi.org/10.1016/j.devcel.2013.06.002
The transcription factor OCT4 is a cornerstone of pluripotency, and yet OCT4 has also been associated with
differentiation in a number of contexts. Reporting in this issue of Developmental Cell, Frum et al. (2013) show
that OCT4’s major early activity in the blastocyst is to support primitive endoderm differentiation.Cells from the early embryo are pluripo-
tent, meaning they are able to differentiate
into all future cell types of the later em-
bryo. When cells from the inner cell
mass (ICM) of the mammalian blastocyst
are expanded in vitro, they give rise to em-
bryonic stem cells (ESCs), pluripotent cell
lines that can self-renew in a dish indefi-
nitely. Maintenance of these cells de-
pends on the regulation of key signaling
pathways and a network of transcription
factors sometimes referred to as the plu-
ripotency network. A central member of
this network is OCT4, a POU domain tran-
scription factor. Oct4 is a conserved regu-
lator of embryonic development that also
plays a pivotal role in the reprogramming
of somatic cells to induced pluripotent
cells (iPSCs), acting as transcriptional
activator of the pluripotency network
(Hammachi et al., 2012). Oct4 is ex-
pressed from the earliest stages of
mammalian development, when it is
thought to block extraembryonic tropho-
blast differentiation (Nichols et al., 1998).
In its absence, ESCs differentiate into
trophoblast (Niwa et al., 2000). OCT4 pro-
tein is also transiently expressed in
emerging extraembryonic primitive en-
doderm (PE) while continuing to be ex-
pressed in the epiblast. In postimplanta-
tion embryos it is expressed throughout
the embryonic epiblast and then becomes
restricted to the primitive streak, where
cells are preparing to differentiate. The
expression of Oct4 in uncommitted cells
alongside its central role in both ESCs
and iPSCs has led to the notion that it is
merely an inhibitor of differentiation. How-
ever, Oct4 expression is also necessary
for in vitro and in vivo differentiation into
the three embryonic germ layers, asESCs/iPSCs expressing low OCT4 levels
become locked into a self-renewing
state (Radzisheuskaya et al., 2013). More-
over, when overexpressed in ESCs, OCT4
can induce differentiation (Niwa et al.,
2000), although increasing the ability of
OCT4 to activate transcription results in
cytokine-independent self-renewal rather
than inducing differentiation (Hammachi
et al., 2012). Consequently, we are left
wondering why a factor required for self-
renewal also promotes differentiation. In
this issue of Developmental Cell, Frum
et al. (2013) provide insight into this
question by demonstrating that while
Oct4 promotes proliferation of the entire
blastocyst, it appears to be specifically
required to support differentiating PE
precursors.
Patterning of the preimplantation
mouse embryo leads to the segregation
of three lineages (trophectoderm, TE;
primitive endoderm, PE; epiblast, EPI) at
the late blastocyst stage (Figure 1). Line-
age determinants such as NANOG (EPI)
and GATA6 (PE) are initially coexpressed
with OCT4 and CDX2 (TE) throughout
the cells of the morula and early blasto-
cyst (Dietrich and Hiiragi, 2007; Morgani
et al., 2013). After cavitation, the ICM be-
comes a heterogeneous salt-and-pepper
mixture of PE and EPI precursors, alterna-
tively expressing Nanog (EPI) or Gata6
(PE) (Chazaud and Rossant, 2006). This
mutually exclusive expression pattern de-
pends on FGF4 secreted by Nanog-ex-
pressing cells (Frankenberg et al., 2011;
Kang et al., 2013). Frum et al. (2013)
show that initial specification of ICM, PE,
and EPI precursors is independent of
both zygotic and maternal Oct4. How-
ever, although ICM, PE, and EPI precur-Developmental Cellsors’ initial specification is unaffected in
Oct4 null early blastocysts, PE cells then
disappear concordantly with a small in-
crease in the number of NANOG-positive
epiblast cells. Thus, in the absence of
Oct4, although GATA6 is expressed in
the ICM, these cells fail to segregate into
stable, expanding PE precursors that
can go on to express other downstream
PE determinants such as SOX17.
One way of thinking about the role that
OCT4 plays during PE specification is
that it drives the segregation of lineage
states in the blastocyst. Frum et al.
(2013) show that in its absence, GATA6
expression cannot be sustained in ICM
cells and is also ectopically expressed in
the CDX2-positive trophoblast. Because
FGF signaling is essential for the segrega-
tion of PE and EPI lineages, the authors
next asked whether OCT4 acts through
the FGF pathway to promote PE and EPI
lineage segregation. When Oct4-null em-
bryos were cultured in FGF signaling in-
hibitors, the majority of ICM cells in these
mutants became NANOG and GATA6
double-positive, as if early cells that may
have coexpressed these factors could
no longer resolve their lineage identity.
This phenotype closely resembles a state
recently observed in embryos cultured in
both GSK and FGF signaling inhibitors,
in which blastocysts contained cells stuck
in a totipotent state coexpressing both
NANOG and early endoderm determi-
nants (Morgani et al., 2013).
The authors next asked whether seg-
regation of cellular identity could be
rescued by exogenous FGF. Although
Oct4-null cells can still respond to FGF,
as previously shown by trophectoderm
proliferation in Oct4-null ICM outgrowths25, June 24, 2013 ª2013 Elsevier Inc. 547
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Figure 1. Oct4 and Lineage Segregation in the Blastocyst
Totipotent blastomeres of the early embryo (E2.5) display overlapping expression of lineage determinants
(GATA6, NANOG, and CDX2). In wild-type unmanipulated embryos, expression of lineage determinants
becomesmutually exclusive, resulting in three segregated lineages. CDX2 expression increases in the tro-
phectoderm (TE) layer and is absent in inner cell mass (ICM). In the ICM, under the influence of FGF
signaling, NANOG-expressing epiblast (EPI) precursors segregate from GATA6-positive primitive endo-
derm (PE). Oct4-null embryos show defective lineage choice and fail to maintain primitive endoderm
(PE). InOct4-null embryos, expression of NANOG (EPI) and GATA6 (PE) is initiated, but ICM cells continue
to coexpress NANOG and GATA6, and some trophoblast cells also express GATA6. At the late blastocyst
stage, GATA6 expression in the ICM is completely lost, although some trophoblast cells still coexpress
CDX2 and GATA6. The rightmost column shows the effect of FGF/MAPK inhibition. In normal embryos
all ICM cells become NANOG positive, while in mutants most of the cells coexpress NANOG and GATA6.
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Previewstreated with FGF4 (Nichols et al., 1998),
FGF was unable to robustly induce
GATA6 expression in Oct4-null ICM cells.
When wild-type ESCs were introduced
back into Oct4-null embryos, they were
unable to rescue the ability of Oct4-null
cells to become PE, indicating that these
cells have a true cell-autonomous defect
in endoderm differentiation. Thus, Oct4-
null cells are unable to effectively respond
to FGF-mediated lineage segregation sig-
nals. However, other inputs play a role in
this decision, because the phenotype
induced by pharmacological blockade of
signaling downstream of the FGF recep-
tor and Oct4 deletion produced a more
severe lineage segregation phenotype.
The results presented by Frum et al.
(2013) are exciting but leave us with a548 Developmental Cell 25, June 24, 2013 ª2conundrum. Shouldn’t Oct4, a central plu-
ripotency factor required for both main-
taining pluripotency in ESCs and inducing
reprogramming, feature in the specifica-
tion of the pluripotent epiblast? The au-
thors describe RNA-seq analysis of
Oct4-null embryos that show that deter-
minants of both EPI and PE lineages are
reduced. Perhaps this reflects a require-
ment for paracrine interactions between
the lineages depicted in Figure 1, with
PE supporting the expansion of EPI pre-
cursors rather than a cell-autonomous
requirement for Oct4 in the EPI precursors
themselves. However, it could also repre-
sent a failure to segregate and establish
both lineages, and this may be a general
property of Oct4. Thus, the role of Oct4
in later differentiation or reprogramming013 Elsevier Inc.may reflect a general function in the stabi-
lization of new lineage programs. A link
to mitogen-activated protein kinase
signaling competence, a central player in
differentiation, may explain OCT4’s role
in gastrulation and could underlie the
conserved nature of Oct4-like proteins,
in which homologs from species without
preimplantation development can sup-
port ESC self-renewal (Hammachi et al.,
2012). Even in mammals, Oct4 is ex-
pressed not only in these early PE cells,
but also in other populations that are
poised, but not committed, for differentia-
tion to multiple lineages. Is OCT4 able to
support differentiation potency by sup-
porting the expansion and segregation
of these uncommitted precursors? It will
surely be interesting to explore the extent
to which other lineages require OCT4 and
why it is required for reprogramming, the
ontogeny of germ cells, and ESC self-
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